Richard E. Uihlein
Director, 10% Owner · GALECTIN THERAPEUTICS INC
Individual
- 2026
- Aug 4, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Richard E. Uihlein files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- 10X Fund, L.P. - $2.43M in GALT purchases and sales in the last 12 months
- Khurram Jamil - $1.44M in GALT purchases and sales in the last 12 months
- Jack W. Callicutt - $944K in GALT purchases and sales in the last 12 months
- Joel Lewis - $621K in GALT purchases and sales in the last 12 months
- Harold H. Shlevin - $501K in GALT purchases and sales in the last 12 months
- Kevin D. Freeman - $20K in GALT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Richard E. Uihlein?
Richard E. Uihlein is a corporate insider, tracked as Director, 10% Owner of GALECTIN THERAPEUTICS INC (GALT). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Richard E. Uihlein submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
